Entertainment

Control Resonant sells 1 million copies in three weeks

Vince MaglayaPublished 20m ago2 min readBased on 5 sources
Control Resonant sells 1 million copies in three weeks
Photo by Sirius Df on Pexels

Control Resonant has sold 1 million copies in roughly three weeks.

Remedy Entertainment confirmed the figure following the game's release on 24 September 2026, as reported by Eurogamer. That pace makes it the fastest-selling game in the studio's 31-year history.

The previous record belonged to Alan Wake 2. That game took about two months to reach 1 million copies after its launch in 2023.

Chief executive Jean-Charles Gaudechon, who took over as head of Remedy in February, described the sales start as a "very strong start". The result carries extra weight because Control Resonant is Remedy's first self-published release of this scale, meaning the studio funded and released the game itself rather than working through an outside publisher.

The road to launch was short and clearly signposted. Remedy revealed Control Resonant on 12 December 2025 with a planned 2026 launch, according to the company's news archive. It then shared new gameplay details on 13 February 2026 before announcing on 2 June 2026 that the worldwide launch date would be 24 September. All dates are credited to Remedy.

The early pace is well ahead of the original Control. That game sold 2 million copies by the end of 2020, about 15 months after launch.

It also came despite problems before release. Control Resonant leaked and was cracked and pirated around launch, as reported by IGN. The studio has not linked the leak to a specific sales impact.

For context, Alan Wake 2 has now passed 3 million copies sold. That game took more than a year to turn a profit, a reminder that development and marketing costs can take time to recoup even after a strong sales milestone.

Critical response has been more mixed than the commercial start. Eurogamer reviewer Alexis Ong gave Control Resonant three stars.

What makes this stand out is the publishing model. When a studio self-publishes, it keeps a larger share of each sale but also carries more of the cost and risk. A fast start does not guarantee long-term profit. It does give Remedy a stronger base to build from.